| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680514 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 11 Pages |
Abstract
Inclusion criteria influence the observed rate of worsening in outcome measures. This has implications for trial design.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Daniela Bertens, Betty M. Tijms, Lisa Vermunt, Niels D. Prins, Philip Scheltens, Pieter Jelle Visser, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative,